{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:24:45Z","timestamp":1790364285937,"version":"4.1.0"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.neuroscience.2026.06.026","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:23:02Z","timestamp":1781911382000},"page":"297-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Molecular crosstalk between MAPK signaling and neuroprotective pathways in Parkinson\u2019s disease: from pathogenesis to therapeutic potential"],"prefix":"10.1016","volume":"610","author":[{"given":"Manar G.","family":"Shalabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder M.","family":"Al-kuraishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5221-4666","authenticated-orcid":false,"given":"Mustafa M.","family":"Shokr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2026.06.026_b0005","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3390\/jpm12050825","article-title":"Association between statin use and risk of parkinson\u2019s disease: evidence from 18 observational studies comprising 3.7 million individuals","volume":"12","author":"Wu","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0010","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jamaneurol.2020.0428","article-title":"Identification of risk loci for parkinson disease in Asians and comparison of risk between Asians and Europeans: a genome-wide association study","volume":"77","author":"Foo","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0015","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9923331","article-title":"The positive role and mechanism of herbal medicine in parkinson\u2019s disease","volume":"2021","author":"Yin","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ncl.2019.12.002","article-title":"Pharmacologic treatment of motor symptoms associated with parkinson\u2013\u2013\u2013\u2013 disease","volume":"38","author":"Poewe","year":"2020","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s40001-024-01779-7","article-title":"Role of GABA pathway in motor and non-motor symptoms in Parkinson\u2019s disease: a bidirectional circuit","volume":"29","author":"Alharbi","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0030","doi-asserted-by":"crossref","DOI":"10.1007\/s11302-026-10160-8","article-title":"Purinergic modulation in Parkinson\u2019s disease: the dual role of istradefylline in motor and cognitive outcomes","volume":"22","author":"Rejili","year":"2026","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.107158","article-title":"Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: a comparative study with tranylcypromine","volume":"128","author":"Zarrilli","year":"2024","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0040","doi-asserted-by":"crossref","DOI":"10.1007\/s11302-025-10114-6","article-title":"The potential role of adenosinergic pathway and methylxanthines in Parkinson\u2019s disease: blowing in the wind or not","volume":"22","author":"Ismail","year":"2026","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10787-022-01125-5","article-title":"SIRT1 pathway in Parkinson\u2019s disease: a faraway snapshot but so close","volume":"31","author":"Batiha","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0050","doi-asserted-by":"crossref","DOI":"10.1007\/s11011-026-01807-x","article-title":"Role of insulin-like growth factor-1\/2 and related signaling in parkinson\u2019s disease","volume":"41","author":"Manni","year":"2026","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177830","article-title":"LRP1 at the crossroads of parkinson\u2019s and alzheimer\u2019s: divergent roles in \u03b1-synuclein and amyloid pathology","volume":"1002","author":"Alshahrani","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0060","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2012.06.025","article-title":"Gene-environment interactions in Parkinson\u2019s disease: specific evidence in humans and mammalian models","volume":"57","author":"Cannon","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2025.157010","article-title":"Dysregulation of the leukotriene pathway in Parkinson\u2019s disease: the potential role of montelukast","volume":"194","author":"Alshahrani","year":"2025","journal-title":"Cytokine"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s10038-022-01058-5","article-title":"Molecular genetics of Parkinson\u2019s disease: contributions and global trends","volume":"68","author":"Funayama","year":"2023","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0075","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2174\/1871527322666230616092054","article-title":"Prevention of parkinson\u2019s disease: from risk factors to early interventions","volume":"23","author":"Ng","year":"2023","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0080","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3233\/JPD-230376","article-title":"Parkinson\u2019s disease is predominantly a genetic disease","volume":"14","author":"Lim","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0085","doi-asserted-by":"crossref","first-page":"8928","DOI":"10.1007\/s12035-024-04128-1","article-title":"Unraveling dysregulated cell signaling pathways, genetic and epigenetic mysteries of parkinson\u2019s disease","volume":"61","author":"Hamidpour","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0090","doi-asserted-by":"crossref","first-page":"326-","DOI":"10.1007\/s11011-025-01739-y","article-title":"Rewiring brain immunity: targeting microglial metabolism for neuroprotection in neurodegenerative disorders","volume":"40","author":"Shokr","year":"2025","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0095","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70540","article-title":"Parkinson\u2019s disease: the epidemiology, risk factors, molecular pathogenesis, prevention, and therapy","volume":"6","author":"Guo","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0100","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.freeradbiomed.2024.02.023","article-title":"Neuroprotective effects of cordycepin on MPTP-induced Parkinson\u2019s disease mice via suppressing PI3K\/AKT\/mTOR and MAPK-mediated neuroinflammation","volume":"216","author":"Wang","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0105","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neuro.2015.12.008","article-title":"Electromagnetic pulse activated brain microglia via the p38 MAPK pathway","volume":"52","author":"Yang","year":"2016","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-017-0805-x","article-title":"Microglia-derived IL-1\u03b2 contributes to axon development disorders and synaptic deficit through p38-MAPK signal pathway in septic neonatal rats","volume":"14","author":"Han","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0115","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.3390\/ijms23052744","article-title":"Mitogen-activated protein kinase and substrate identification in plant growth and development","volume":"23","author":"Jiang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0120","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/ijms23010370","article-title":"The p38 MAPK components and modulators as biomarkers and molecular targets in cancer","volume":"23","author":"Garc\u00eda-Hern\u00e1ndez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119499","article-title":"Interplay between MAPK\/ERK signaling pathway and MicroRNAs: a crucial mechanism regulating cancer cell metabolism and tumor progression","volume":"278","author":"Asl","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109136","article-title":"Transcriptional co-activator regulates melanocyte differentiation and oncogenesis by integrating cAMP and MAPK\/ERK pathways","volume":"35","author":"Ostoji\u0107","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/15569527.2020.1730882","article-title":"Neferine inhibits epidermal growth factor-induced proliferation and migration of retinal pigment epithelial cells through downregulating p38 MAPK and PI3K\/AKT signalling","volume":"39","author":"Ozal","year":"2020","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0140","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jid.2021.07.164","article-title":"Combined cyclin-dependent kinase inhibition overcomes MAPK\/extracellular signal\u2013regulated kinase kinase inhibitor resistance in plexiform neurofibroma of neurofibromatosis type I","volume":"142","author":"Wang","year":"2022","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0145","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3390\/ijms21072346","article-title":"Understanding MAPK signaling pathways in apoptosis","volume":"21","author":"Yue","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0150","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3390\/ijms23031108","article-title":"Functional roles of JNK and p38 MAPK signaling in nasopharyngeal carcinoma","volume":"23","author":"Pua","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0155","article-title":"ERK\/MAPK signalling pathway and tumorigenesis (Review)","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0160","article-title":"Mechanisms of the JNK\/p38 MAPK signaling pathway in drug resistance in ovarian cancer","volume":"15","author":"Ma","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19102973","article-title":"Role of mitogen activated protein kinase signaling in parkinson\u2019s disease","volume":"19","author":"Bohush","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0170","article-title":"Intermittent ERK oscillations downstream of FGF in mouse embryonic stem cells","volume":"149","author":"Raina","year":"2022","journal-title":"Dev"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0175","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/1759-7714.13430","article-title":"CM082, a novel angiogenesis inhibitor, enhances the antitumor activity of gefitinib on epidermal growth factor receptor mutant non-small cell lung cancer in vitro and in vivo","volume":"11","author":"Zhang","year":"2020","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0180","doi-asserted-by":"crossref","unstructured":"T.R. Caulfield, F.C. Fiesel, E.L. Moussaud-Lamodi\u00e8re, D.F.A.R. Dourado, S.C. Flores, W. Springer, Phosphorylation by PINK1 Releases the UBL Domain and Initializes the Conformational Opening of the E3 Ubiquitin Ligase Parkin, 2014. https:\/\/doi.org\/10.1371\/journal.pcbi.1003935.","DOI":"10.1371\/journal.pcbi.1003935"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0185","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12017-013-8230-5","article-title":"Mitogen-activated protein kinase phosphatase (mkp)-1 as a neuroprotective agent: promotion of the morphological development of midbrain dopaminergic neurons","volume":"15","author":"Collins","year":"2013","journal-title":"NeuroMol. Med."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0190","unstructured":"J. Korbecki, I. Baranowska-Bosiacka, I. Gutowska, D. Chlubek, The effect of reactive oxygen species on the synthesis of prostanoids from arachidonic acid, 2013."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0195","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jocn.2013.08.017","article-title":"Peripheral expression of MAPK pathways in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"21","author":"Wang","year":"2014","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/649079","article-title":"The role of p38 MAPK and its substrates in neuronal plasticity and neurodegenerative disease","volume":"2012","author":"Corr\u00eaa","year":"2012","journal-title":"J. Signal Transduct."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0205","series-title":"Synuclein Affects the MAPK Pathway and Accelerates Cell Death","article-title":"\u03b1-","author":"Iwata","year":"2001"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114874","article-title":"p38 MAPK-DRP1 signaling is involved in mitochondrial dysfunction and cell death in mutant A53T \u03b1-synuclein model of Parkinson\u2019s disease","volume":"388","author":"Gui","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105094","article-title":"Activated microglia facilitate the transmission of \u03b1-synuclein in Parkinson\u2019s disease","volume":"148","author":"Zheng","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0220","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","article-title":"PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0225","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s12640-015-9592-2","article-title":"Doxycycline suppresses microglial activation by inhibiting the p38 MAPK and NF-kB signaling pathways","volume":"29","author":"Santa-Cec\u00edlia","year":"2016","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12950-020-00266-0","article-title":"p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson\u2019s disease","volume":"18","author":"Chen","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.114630","article-title":"PARP1 promotes NLRP3 activation via blocking TFEB-mediated autophagy in rotenone-induced neurodegeneration","volume":"252","author":"Zhang","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105014","article-title":"Role of microgliosis, oxidative stress and associated neuroinflammation in the pathogenesis of Parkinson\u2019s disease: the therapeutic role of Nrf2 activators","volume":"145","author":"Jayaram","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0245","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2174\/1567202616666181123152601","article-title":"ERK\/MAP kinase activation is evident in activated microglia of the striatum and substantia Nigra in an acute and chronically-induced mouse model of parkinson\u2019s disease","volume":"15","author":"Sarkar","year":"2018","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0250","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1471-4159.2009.06112.x","article-title":"Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-\u03baB in MPTP-treated mice: implication in parkinson\u2019s disease","volume":"109","author":"Karunakaran","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0255","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1111\/ejn.15242","article-title":"Nuclear factor-kappa B (NF-\u03baB) in pathophysiology of Parkinson disease: diverse patterns and mechanisms contributing to neurodegeneration","volume":"54","author":"Dolatshahi","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121129","article-title":"Xanthotoxin modulates oxidative stress, inflammation, and MAPK signaling in a rotenone-induced Parkinson\u2019s disease model","volume":"310","author":"Sayed","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0265","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3390\/ijms17081293","article-title":"Oleuropein prevents neuronal death, mitigates mitochondrial superoxide production and modulates autophagy in a dopaminergic cellular model","volume":"17","author":"Achour","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105754","article-title":"NADPH oxidase 2 activity in Parkinson\u2019s disease","volume":"170","author":"Keeney","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0275","doi-asserted-by":"crossref","unstructured":"R. Wu, H. Chen, J. Ma, Q. He, Q. Huang, Q. Liu, M. Li, Z. Yuan, C-Abl-p38\u03b1 signaling plays an important role in MPTP-induced neuronal death, 2016. https:\/\/doi.org\/10.1038\/cdd.2015.135.","DOI":"10.1038\/cdd.2015.135"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0280","doi-asserted-by":"crossref","unstructured":"F. Gao, D. Chen, Q. Hu, G. Wang, Rotenone Directly Induces BV2 Cell Activation via the p38 MAPK Pathway, 2013. https:\/\/doi.org\/10.1371\/journal.pone.0072046.","DOI":"10.1371\/journal.pone.0072046"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0285","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.taap.2018.09.012","article-title":"Montelukast attenuates rotenone-induced microglial activation\/p38 MAPK expression in rats: possible role of its antioxidant, anti-inflammatory and antiapoptotic effects","volume":"358","author":"Mansour","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0290","article-title":"ErbB4 regulate extracellular dopamine through the p38 MAPK signaling pathway","volume":"751","author":"Xia Cao","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0295","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neulet.2012.10.050","article-title":"Neuregulin-1 receptor tyrosine kinase ErbB4 is upregulated in midbrain dopaminergic neurons in Parkinson disease","volume":"531","author":"Depboylu","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0300","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/jnc.13026","article-title":"Systemically administered neuregulin-1\u03b21 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson\u2019s disease","volume":"133","author":"Depboylu","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0305","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/j.1471-4159.2008.05310.x","article-title":"MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation - Relevance in a mouse model of Parkinson\u2019s disease","volume":"105","author":"Thomas","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0310","doi-asserted-by":"crossref","first-page":"e756","DOI":"10.1002\/iid3.756","article-title":"Knockdown of SEMA7A alleviates MPP+-induced apoptosis and inflammation in BV2 microglia via PPAR-\u03b3 activation and MAPK inactivation","volume":"11","author":"Qi","year":"2023","journal-title":"Immunity Inflamm. Dis."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0315","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/labinvest.2009.124","article-title":"Small peptide inhibitor of JNKs protects against MPTP-induced nigral dopaminergic injury via inhibiting the JNK-signaling pathway","volume":"90","author":"Pan","year":"2010","journal-title":"Lab. Investig."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0320","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.neuint.2009.01.013","article-title":"Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3) attenuates dopaminergic neuronal damage in mouse model of Parkinson\u2019s disease","volume":"54","author":"Pan","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0325","doi-asserted-by":"crossref","unstructured":"M.J. Kim, K. Futai, J. Jo, Y. Hayashi, K. Cho, M. Sheng, Synaptic Accumulation of PSD-95 and Synaptic Function Regulated by Phosphorylation of Serine-295 of PSD-95, 2007. https:\/\/doi.org\/10.1016\/j.neuron.2007.09.007.","DOI":"10.1016\/j.neuron.2007.09.007"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0330","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nbd.2017.10.015","article-title":"cJun N-terminal kinase (JNK) mediates cortico-striatal signaling in a model of parkinson\u2019s disease","volume":"110","author":"Spigolon","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0335","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/cddis.2015.27","article-title":"JNK pathway activation is able to synchronize neuronal death and glial phagocytosis in drosophila","volume":"6","author":"Shklover","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0340","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/895975","article-title":"JNK and NADPH oxidase involved in fluoride-induced oxidative stress in BV-2 microglia cells","volume":"2013","author":"Yan","year":"2013","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0345","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/hipo.22497","article-title":"Dopamine D1\/D5 receptor signaling regulates synaptic cooperation and competition in hippocampal CA1 pyramidal neurons via sustained ERK1\/2 activation","volume":"26","author":"Shivarama Shetty","year":"2016","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0350","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1007\/s00204-024-03829-9","article-title":"Unraveling the AKT\/ERK cascade and its role in Parkinson disease","volume":"98","author":"Keshri","year":"2024","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0355","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.22514","article-title":"DJ-1 modulates the expression of Cu\/Zn-superoxide dismutase-1 through the Erk1\/2-Elk1 pathway in neuroprotection","volume":"70","author":"Wang","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0360","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3892\/ijmm.2014.1830","article-title":"Involvement of the ERK pathway in the protective effects of glycyrrhizic acid against the MPP+-induced apoptosis of dopaminergic neuronal cells","volume":"34","author":"Teng","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0365","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3389\/fnins.2020.00577","article-title":"LRRK2 and \u03b1-synuclein: distinct or synergistic players in parkinson\u2019s disease?","volume":"14","author":"O\u2019Hara","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0370","doi-asserted-by":"crossref","first-page":"11744","DOI":"10.3390\/ijms231911744","article-title":"Molecular pathways involved in LRRK2-linked parkinson\u2019s disease: a systematic review","volume":"23","author":"Ravinther","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0375","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1139\/bcb-2017-0262","article-title":"The drosophila hep pathway mediates Lrrk2-induced neurodegeneration","volume":"96","author":"Yang","year":"2018","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0380","doi-asserted-by":"crossref","first-page":"001","DOI":"10.17352\/ojpdt.000001","article-title":"Restoration of mitochondrial dysfunction in 6-hydroxydopamine induced parkinson\u2019s disease: a complete review","volume":"1","author":"Mehan","year":"2017","journal-title":"Open J. Park. Dis. Treat."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0385","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/cdd.2012.42","article-title":"(G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD","volume":"19","author":"Chen","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0390","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1007\/s12640-021-00401-6","article-title":"Understanding abnormal c-JNK\/p38MAPK signaling overactivation involved in the progression of multiple sclerosis: possible therapeutic targets and impact on neurodegenerative diseases","volume":"39","author":"Singh","year":"2021","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0395","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","article-title":"Signaling pathways in parkinson\u2019s disease: molecular mechanisms and therapeutic interventions","volume":"8","author":"Dong-Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0400","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/13543776.2023.2242584","article-title":"A patent review of MAPK inhibitors (2018\u2013present)","volume":"33","author":"Wydra","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0405","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ctrv.2013.01.003","article-title":"Effect of inhibition of the FGFR-MAPK signaling pathway on the development of ocular toxicities","volume":"39","author":"Van der Noll","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0410","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1468-3083.2012.04546.x","article-title":"Cutaneous side effects of inhibitors of the RAS\/RAF\/MEK\/ERK signalling pathway and their management","volume":"27","author":"Manousaridis","year":"2013","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0415","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.jmb.2020.01.037","article-title":"Autophagy in parkinson\u2019s disease","volume":"432","author":"Hou","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177419","article-title":"Dysregulation of serotonergic neurotransmission in Parkinson disease: a key duet","volume":"995","author":"Khowdiary","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0425","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.691881","article-title":"The cross-links of endoplasmic reticulum stress, autophagy, and neurodegeneration in parkinson\u2019s disease","volume":"13","author":"Ren","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0430","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10517-021-05242-z","article-title":"Restoration of parkinson\u2019s disease-like deficits by activating autophagy through mTOR-dependent and mTOR-independent mechanisms in pharmacological and transgenic models of parkinson\u2019s disease in mice","volume":"171","author":"Pupyshev","year":"2021","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0435","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1080\/15548627.2016.1238555","article-title":"Targeting neuronal MAPK14\/p38\u03b1 activity to modulate autophagy in the alzheimer disease brain","volume":"12","author":"Alam","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0440","doi-asserted-by":"crossref","first-page":"7872","DOI":"10.18632\/aging.202805","article-title":"PI3K\/AKT\/MTOR and ERK1\/2-MAPK signaling pathways are involved in autophagy stimulation induced by caloric restriction or caloric restriction mimetics in cortical neurons","volume":"13","author":"Ferreira-Marques","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0445","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/0963689719857085","article-title":"MicroRNA-101a regulates autophagy phenomenon via the MAPK pathway to modulate alzheimer\u2019s-associated pathogenesis","volume":"28","author":"Li","year":"2019","journal-title":"Cell Transplant."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0450","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neures.2023.12.001","article-title":"Unveiling the regulatory of miR-101-3p on ZNF746 in a parkinson\u2019s disease cell model: implications for therapeutic targeting","volume":"203","author":"Mahmoudian Esfahani","year":"2024","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0455","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.599246","article-title":"LncRNA-T199678 mitigates \u03b1-synuclein-induced dopaminergic neuron injury via miR-101-3p","volume":"12","author":"Bu","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0460","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1152\/jn.00240.2021","article-title":"Role of the p38MAPK signaling pathway in hippocampal neuron autophagy in rats with chronic intermittent hypoxia","volume":"126","author":"He","year":"2021","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0465","first-page":"2","volume":"1","author":"Meng","year":"2022","journal-title":"Oxidative Stress Induced by Realgar in Neurons, P38 MAPK"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-02023-9","article-title":"Substantia nigra Smad3 signaling deficiency: relevance to aging and Parkinson\u2019s disease and roles of microglia, proinflammatory factors, and MAPK","volume":"17","author":"Liu","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0475","doi-asserted-by":"crossref","first-page":"15330","DOI":"10.3390\/ijms232315330","article-title":"The PI3K\/Akt pathway in meta-inflammation","volume":"23","author":"Acosta-Martinez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0480","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.648636","article-title":"PI3K\/AKT signal pathway: a target of natural products in the prevention and treatment of alzheimer\u2019s disease and parkinson\u2019s disease","volume":"12","author":"Long","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0485","article-title":"Baicalin attenuates oxygen\u2013glucose deprivation\/reoxygenation\u2013induced injury by modulating the BDNF-TrkB\/PI3K\/Akt and MAPK\/Erk1\/2 signaling axes in neuron\u2013astrocyte cocultures","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0490","doi-asserted-by":"crossref","first-page":"e1775","DOI":"10.1038\/cddis.2015.146","article-title":"Activation of transient receptor potential vanilloid 4 induces apoptosis in hippocampus through downregulating PI3K\/Akt and upregulating p38 MAPK signaling pathways","volume":"6","author":"Jie","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115496","article-title":"GSK-3\u03b2: an exuberating neuroinflammatory mediator in parkinson\u2019s disease","volume":"210","author":"Samim Khan","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0500","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1007\/s12035-024-04003-z","article-title":"Therapeutic potential effect of glycogen synthase kinase 3 beta (GSK-3\u03b2) inhibitors in parkinson disease: exploring an overlooked avenue","volume":"61","author":"Turkistani","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0505","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/1074248412438102","article-title":"Curcumin protects against regional myocardial ischemia\/reperfusion injury through activation of RISK\/GSK-3\u03b2 and inhibition of p38 MAPK and JNK","volume":"17","author":"Jeong","year":"2012","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174069","article-title":"Eriodictyol inhibits glioblastoma migration and invasion by reversing EMT via downregulation of the P38 MAPK\/GSK-3\u03b2\/ZEB1 pathway","volume":"900","author":"Lv","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0515","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/14728222.2018.1526925","article-title":"Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging","volume":"22","author":"Duda","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0520","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.248187","article-title":"Protein phosphatase 2A \u2013 Structure, function and role in neurodevelopmental disorders","volume":"134","author":"Sandal","year":"2021","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0525","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.20892\/j.issn.2095-3941.2022.0330","article-title":"Targeting PP2A for cancer therapeutic modulation","volume":"19","author":"Ronk","year":"2022","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0530","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s12035-021-02670-w","article-title":"Cancerous inhibitor of protein phosphatase 2A (CIP2A): could it be a promising biomarker and therapeutic target in parkinson\u2019s disease?","volume":"59","author":"Yin","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105426","article-title":"Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulation","volume":"157","author":"Drouyer","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0540","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/acn3.337","article-title":"Dysregulation of protein phosphatase 2A in parkinson disease and dementia with lewy bodies","volume":"3","author":"Park","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0545","doi-asserted-by":"crossref","first-page":"H2204","DOI":"10.1152\/ajpheart.01050.2003","article-title":"Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes","volume":"286","author":"Liu","year":"2004","journal-title":"Am. J. Physiol. - Hear. Circ. Physiol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0550","doi-asserted-by":"crossref","first-page":"10063","DOI":"10.1038\/srep10063","article-title":"Basal protein phosphatase 2A activity restrains cytokine expression: role for MAPKs and tristetraprolin","volume":"5","author":"Rahman","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0555","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0002-9440(10)63445-1","article-title":"Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1\/2, MEK1\/2, and p70 S6, similar to that in Alzheimer\u2019s disease","volume":"163","author":"Pei","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0560","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/j.ejca.2011.08.014","article-title":"Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathway","volume":"47","author":"Li","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0565","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/neup.12633","article-title":"Phosphatase and tensin homolog deletion enhances neurite outgrowth during neural stem cell differentiation","volume":"40","author":"Shen","year":"2020","journal-title":"Neuropathology"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0570","doi-asserted-by":"crossref","first-page":"9838","DOI":"10.3390\/ijms22189838","article-title":"Pi3k\/pten\/akt signaling pathways in germ cell development and their involvement in germ cell tumors and ovarian dysfunctions","volume":"22","author":"De Felici","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0575","doi-asserted-by":"crossref","DOI":"10.1186\/s13229-020-00406-6","article-title":"Cross-level analysis of molecular and neurobehavioral function in a prospective series of patients with germline heterozygous PTEN mutations with and without autism, 1-4","volume":"12","author":"Frazier","year":"2021","journal-title":"Mol. Autism."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0580","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1074\/jbc.M112.391680","article-title":"Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1)-dependent ubiquitination of endogenous parkin attenuates mitophagy: study in human primary fibroblasts and induced pluripotent stem cell-derived neurons","volume":"288","author":"Rakovic","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0585","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.neuint.2012.01.031","article-title":"Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson\u2019s disease","volume":"61","author":"Braithwaite","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0590","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00109-011-0844-1","article-title":"The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms","volume":"90","author":"Ciuffreda","year":"2012","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0595","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1074\/jbc.M511105200","article-title":"Up-regulation of PTEN (phosphatase and tensin homolog deleted on chromosome ten) mediates p38 MAPK stress signal-induced inhibition of insulin signaling: a cross-talk between stress signaling and insulin signaling in resistin-treated human endothelial cel","volume":"281","author":"Shen","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0600","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1063","article-title":"Pros and cons for statins use and risk of parkinson\u2019s disease: an updated perspective","volume":"11","author":"Al-kuraishy","year":"2023","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0605","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3390\/brainsci12101290","article-title":"Statins use in alzheimer disease: bane or boon from frantic search and narrative review","volume":"12","author":"Alsubaie","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0610","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.1471-4159.2008.05254.x","article-title":"Statins reduce neuronal \u03b1-synuclein aggregation in in vitro models of parkinson\u2019s disease","volume":"105","author":"Bar-On","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0615","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/mds.27006","article-title":"Statins may facilitate parkinson\u2019s disease: insight gained from a large, national claims database","volume":"32","author":"Liu","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0620","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/aps.2013.203","article-title":"Atorvastatin prevents amyloid-\u03b2 peptide oligomer-induced synaptotoxicity and memory dysfunction in rats through a p38 MAPK-dependent pathway","volume":"35","author":"Zhang","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0625","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/glia.22974","article-title":"Simvastatin and atorvastatin facilitates amyloid \u03b2-protein degradation in extracellular spaces by increasing neprilysin secretion from astrocytes through activation of MAPK\/Erk1\/2 pathways","volume":"64","author":"Yamamoto","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0630","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s11064-016-1913-1","article-title":"Atorvastatin prevents glutamate uptake reduction induced by quinolinic acid via MAPKs signaling","volume":"41","author":"Vandresen-Filho","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0635","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fnmol.2018.00165","article-title":"Simvastatin inhibits activation of nadph oxidase\/p38 MAPK pathway and enhances expression of antioxidant protein in parkinson disease models","volume":"11","author":"Tong","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0640","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/14656566.2021.1985465","article-title":"An overview of alogliptin + pioglitazone for the treatment of type 2 diabetes","volume":"23","author":"Tomlinson","year":"2022","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0645","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neulet.2017.04.052","article-title":"Pioglitazone improves the ability of learning and memory via activating ERK1\/2 signaling pathway in the hippocampus of T2DM rats","volume":"651","author":"Gao","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0650","doi-asserted-by":"crossref","first-page":"16725","DOI":"10.1523\/JNEUROSCI.2153-12.2012","article-title":"Cognitive enhancement with rosiglitazone links the hippocampal PPAR\u03b3 and ERK MAPK signaling pathways","volume":"32","author":"Denner","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0655","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00011-010-0203-7","article-title":"PPAR\u03b3 agonist pioglitazone inhibits microglia inflammation by blocking p38 mitogen-activated protein kinase signaling pathways","volume":"59","author":"Huoyan","year":"2010","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0660","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1973","article-title":"Enhancement of select cognitive domains with rosiglitazone implicates dorsal hippocampus circuitry sensitive to PPAR\u03b3 agonism in an alzheimer\u2019s mouse model","volume":"11","author":"Cortez","year":"2021","journal-title":"Brain Behav."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0665","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2174\/1871527322666221005122408","article-title":"Neuroprotective and anti-inflammatory effects of pioglitazone on parkinson\u2019s disease: a comprehensive narrative review of clinical and experimental findings","volume":"22","author":"Zamanian","year":"2022","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0670","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jocn.2022.10.023","article-title":"Pioglitazone use is associated with reduced risk of parkinson\u2019s disease in patients with diabetes: a systematic review and meta-analysis","volume":"106","author":"Chen","year":"2022","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0675","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4103\/bbrj.bbrj_26_20","article-title":"Fenofibrate and crataegus oxyacantha is an effectual combo for mixed dyslipidemia","volume":"4","author":"Rasheed","year":"2020","journal-title":"Biomed. Biotechnol. Res. J."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0680","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pnpbp.2014.02.009","article-title":"PPAR-\u03b1 agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson\u2019s disease","volume":"53","author":"Barbiero","year":"2014","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0685","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/FBP.0000000000000699","article-title":"Fenofibrate promotes neuroprotection in a model of rotenone-induced parkinson\u2019s disease","volume":"33","author":"Barbiero","year":"2022","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0690","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/753587","article-title":"Neuroprotective potential of peroxisome proliferator activated receptor-\u03b1 agonist in cognitive impairment in parkinson\u2019s disease: behavioral, biochemical, and PBPK profile","volume":"2014","author":"Uppalapati","year":"2014","journal-title":"PPAR Res."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0695","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s12035-014-8882-7","article-title":"PPAR\u03b1 agonist fenofibrate ameliorates learning and memory deficits in rats following global cerebral ischemia","volume":"52","author":"Xuan","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0700","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijdevneu.2014.10.004","article-title":"Fenofibrate reduces amyloidogenic processing of APP in APP\/PS1 transgenic mice via PPAR-\u03b1\/PI3-K pathway","volume":"38","author":"Zhang","year":"2014","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0705","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3390\/ijms23010398","article-title":"Metformin repurposing for parkinson disease therapy: opportunities and challenges","volume":"23","author":"Agostini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0710","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.clnesp.2024.02.018","article-title":"Metformin use is associated with reduced mortality risk in diabetic patients with parkinson\u2019s disease","volume":"60","author":"Pezzoli","year":"2024","journal-title":"Clin. Nutr. ESPEN"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136708","article-title":"Metformin protects against pericyte apoptosis and promotes neurogenesis through suppressing JNK p38 MAPK signalling activation in ischemia\/reperfusion injury","volume":"783","author":"Liu","year":"2022","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0720","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1007\/s10787-025-01955-z","article-title":"Beyond the blood\u2013brain barrier: unraveling T cell subsets in CNS immunity and disease","volume":"33","author":"Shokr","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0725","article-title":"Regulation mechanism of curcumin mediated inflammatory pathway and its clinical application: a review","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0730","doi-asserted-by":"crossref","first-page":"15108","DOI":"10.1007\/s12035-025-05113-y","article-title":"Targeting of the PI3 K\/AKT\/GSK3\u03b2 pathway in parkinson\u2019s disease: a therapeutic blueprint","volume":"62","author":"AlRuwaili","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e41002","article-title":"Neuroprotective effects of baicalin and baicalein on the central nervous system and the underlying mechanisms","volume":"11","author":"Si","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0740","first-page":"2356","article-title":"LRRK2 functions as a scaffolding kinase of ASK1-mediated neuronal cell death","volume":"2017","author":"Yoon","year":"1864","journal-title":"Biochim. Biophys. Acta - Mol. Cell Res."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0745","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1046\/j.1471-4159.2000.0751200.x","article-title":"MPTP activates c-Jun NH2-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo","volume":"75","author":"Saporito","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0750","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030728","article-title":"Balancing mTOR signaling and autophagy in the treatment of Parkinson\u2019s disease","volume":"20","author":"Zhu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0755","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cyto.2009.08.002","article-title":"Regulation of JNK and p38 MAPK in the immune system: signal integration, propagation and termination","volume":"48","author":"Huang","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.neuroscience.2026.06.026_b0760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21124471","article-title":"Map\/erk signaling in developing cognitive and emotional function and its effect on pathological and neurodegenerative processes","volume":"21","author":"Albert-Gasc\u00f3","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.06.026_b0765","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00702-023-02635-4","article-title":"The heterogeneity of Parkinson\u2019s disease","volume":"130","author":"W\u00fcllner","year":"2023","journal-title":"J. Neural Transm."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645222600415X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645222600415X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:11:50Z","timestamp":1784131910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030645222600415X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":153,"alternative-id":["S030645222600415X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.06.026","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular crosstalk between MAPK signaling and neuroprotective pathways in Parkinson\u2019s disease: from pathogenesis to therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.06.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}